Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC91375 structure
    GC91375Promethazine Sulfoxide
    CAS: 7640-51-9
    纯度: >95.00%

    盐酸普罗米嗪是组胺H1受体拮抗剂普罗米嗪的代谢产物。它由细胞色素P450(CYP)同工酶CYP2D6将普罗米嗪转化而成。

  • GC91379 structure
    GC91379BDW568
    CAS: 335401-44-0
    纯度: >98.00%

    BDW568是干扰素基因刺激剂(STING)的激动剂,也是BDW-OH.1的前药形式。

  • GC91380 structure
    GC91380N6F11
    CAS: 851398-76-0
    纯度: >99.50%

    N6F11 is a novel, selective and potent inducer of iron death with anticancer and antitumour activity that promotes GPX4 degradation by binding to TRIM25 in cancer cells.

  • GC91389 structure
    GC91389J27644
    纯度: >95.00%

    J27644是一种组蛋白去乙酰化酶6(HDAC6)的抑制剂(IC50 = 10 nM)。它选择性地作用于HDAC6,而不影响HDAC1-5(IC50s = 211-516 nM)和HDAC7、8、9和11(IC50s = 137-812 nM)。

  • GC91397 structure
    GC91397N-desmethyl Levofloxacin (hydrochloride)
    纯度: >98.00%

    N-去甲基左氧氟沙星是氟喹诺酮类抗生素左氧氟沙星的活性代谢产物。它对金黄色葡萄球菌、表皮葡萄球菌、枯草杆菌、大肠杆菌、铜绿假单胞菌和肺炎克雷伯杆菌具有活性(最小抑制浓度分别为4,1,1,0.012,> 4和0.25μg/ml)。

  • GC91406 structure
    GC91406UK 122 (trifluoroacetate salt)
    CAS: 1186653-73-5
    纯度: >95.00%

    UK 122是一种尿激酶型纤溶酶原激活剂(uPA)抑制剂(IC50 = 0.2 uM)。它选择性地作用于uPA,而不影响组织型纤溶酶原激活剂(tPA)、胰蛋白酶、纤溶酶和凝血酶(所有的IC50均大于100uM)。

  • GC91424 structure
    GC91424S1PL-IN-31
    CAS: 1538574-95-6
    纯度: >98.00%

    S1PL-IN-31是一种抑制神经酰胺-1-磷酸(S1P)裂解酶的抑制剂(IC50 = 210 nM)。它也是平滑蛋白受体(Smo)的拮抗剂(IC50 = 440 nM)。

  • GC91449 structure
    GC91449Ipamorelin (acetate)
    纯度: >98.00%

    Ipamorelin是一种五肽生长激素分泌素(GHS)和GHS受体1a(GHS-R1a)激动剂。

  • GC91590 structure
    GC91590DTPD-Q
    CAS: 252950-56-4
    纯度: >98.00%

    DTPD-Q is an oxidized derivative of the antioxidant and methylphenyl substituted p-phenylenediamine DTPD.

  • GC91595 structure
    GC91595PDIC-NC
    CAS: 2633013-75-7
    纯度: >95.00%

    PDIC-NC is an activator of stimulator of interferon genes (STING) and an anticancer agent.

  • GC91598 structure
    GC91598GPX4 16
    CAS: 2644044-43-7
    纯度: >98.00%

    GPX4 16 is an inhibitor of glutathione peroxidase 4 (GPX4).

  • GC91612 structure
    GC91612FDW028
    CAS: 2768426-49-7
    纯度: >98.00%

    FDW028 is an inhibitor of fucosyltransferase 8 (FUC8).

  • GC91623 structure
    GC91623Ferroptosis Inducer 24
    CAS: 28657-88-7
    纯度: >95.00%

    Ferroptosis inducer 24 is an inducer of ferroptosis.

  • GC91659 structure
    GC91659BDW-OH
    CAS: 573976-22-4
    纯度: >95.00%

    BDW-OH is an active metabolite of the STING agonist and prodrug BDW568 .

  • GC91670 structure
    GC91670MRSA Antibiotic 1
    CAS: 667410-81-3
    纯度: >95.00%

    MRSA antibiotic 1 is an antibiotic.

  • GC91673 structure
    GC91673CPPD-Q
    CAS: 68054-78-4
    纯度: >95.00% / >98.00%

    CPPD-Q是一种抗氧化剂CPPD的氧化衍生物,具有抑菌和杀虫作用。

  • GC91680 structure
    GC916804-Acetamido Antipyrine
    CAS: 83-15-8
    纯度: >95.00%

    4-Acetamido antipyrine (4-AAAP) is an active metabolite of the non-opioid analgesic and antipyretic prodrug metamizole .

  • GC91681 structure
    GC91681Loxoprofen-SRS
    CAS: 83648-76-4
    纯度: >98.00%

    Loxoprofen-SRS is a non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (IC50s = 0.5 and 0.39 for recombinant human COX-1 and COX-2, respectively) and an active metabolite of the prodrug loxoprofen .

  • GC91688 structure
    GC91688PDIC-NN
    CAS: 932740-48-2
    纯度: >95.00%

    PDIC-NN is an intermediate in the synthesis of PDIC-NS , an activator of stimulator of interferon genes (STING) with anticancer activity.

  • GC91690 structure
    GC91690TASP0277308
    CAS: 945725-50-8
    纯度: >98.00%

    TASP0277308 is a sphingosine-1-phosphate receptor 1 (S1P1) antagonist (IC50 = 4.2 nM).

  • GC91768 structure
    GC91768GSK205 (hydrobromide)
    纯度: >95.00%

    GSK205 is an inhibitor of transient receptor potential vanilloid 4 (TRPV4) and transient receptor potential ankyrin 1 (TRPA1; IC50s = 4.19 and 5.56 µM, respectively, for the rat channels).

  • GC91776 structure
    GC91776PD-1/PD-L1 Inhibitor N11
    纯度: >95.00%

    PD-1/PD-L1 inhibitor N11 is an inhibitor of the protein-protein interaction between programmed cell death protein 1 (PD-1) and PD-1 ligand (PD-L1; IC50 = 6.3 nM).

  • GC91777 structure
    GC91777NVS-STG2
    纯度: >98.00%

    NVS-STG2 is an agonist of stimulator of interferon genes (STING).

  • GC91783 structure
    GC91783FA16
    纯度: >95.00%

    FA16 is a ferroptosis inducer and an inhibitor of the system xc- cystine/glutamate transporter.